ARCHIVES

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

This article is from The Cancer Letter archive.

Vol. 12 No. 46 | November 28, 1986

Download PDF Visit The Full Archive

Related Articles

Ovarian Cancer Screening Finds Cancers, But Also Many False Positives, Study Says

November 25, 2005

Named VP, Health sciences At UNM

February 11, 1994

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

NCI-Approved Clinical Trials

June 24, 2005

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

NCAB Gives Okay To Comp Center Guidelines

December 7, 1979